1. Grønskov, K., Ek, J., & Brondum-Nielsen, K. (2007). Oculocutaneous albinism. Orphanet journal of rare diseases, 2, 43. https://doi.org/10.1186/1750-1172-2-43
2. National Human Genome Research Institute. (n.d.). Autosomal recessive disorder. Genetics Glossary. https://www.genome.gov/genetics-glossary/Autosomal-Recessive-Disorder
3. Mayo Clinic. (n.d.). Albinism: Symptoms and causes. https://www.mayoclinic.org/diseases-conditions/albinism/symptoms-causes/syc-20369184
4. Schlessinger DI, Anoruo MD, Schlessinger J. Biochemistry, Melanin. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459156/
5. Dolinska, M. B., Kus, N. J., Farney, S. K., Wingfield, P. T., Brooks, B. P., & Sergeev, Y. V. (2017). Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity. Pigment cell & melanoma research, 30(1), 41–52. https://doi.org/10.1111/pcmr.12546
6. Hughes, B. K., & Bishop, C. L. (2022). Current understanding of the role of senescent melanocytes in skin ageing. Biomedicines, 10(12), 3111. https://doi.org/10.3390/biomedicines10123111
7. Yuan, X., Dang, Q., & Li, X. L. (2024). Functional analysis of two mutation sites in the OCA2 gene. Scientific Reports, 14, 14789. https://doi.org/10.1038/s41598-024-64782-2
8. Boissy, R. E., Zhao, H., Oetting, W. S., Austin, L. M., Wildenberg, S. C., Boissy, Y. L., Zhao, Y., Sturm, R. A., Hearing, V. J., King, R. A., & Nordlund, J. J. (1996). Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3". American journal of human genetics, 58(6), 1145–1156.
9. Hayashi M, Suzuki T. Oculocutaneous Albinism Type 4. 2005 Nov 17 [Updated 2017 Sep 7]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1510/
10. Ginger, R. S., Askew, S. E., Ogborne, R. M., Wilson, S., Ferdinando, D., Dadd, T., Smith, A. M., Kazi, S., Szerencsei, R. T., Winkfein, R. J., Schnetkamp, P. P., & Green, M. R. (2008). SLC24A5 encodes a trans-Golgi network protein with potassium-dependent sodium-calcium exchange activity that regulates human epidermal melanogenesis. The Journal of biological chemistry, 283(9), 5486–5495. https://doi.org/10.1074/jbc.M707521200
11. Fertl, D., & Rosel, P. E. (2009). Albinism. In W. F. Perrin, B. Würsig, & J. G. M. Thewissen (Eds.), Encyclopedia of Marine Mammals (2nd ed., pp. 24–26). Academic Press. https://doi.org/10.1016/B978-0-12-373553-9.00006-7
12. Zhang, C., Ren, Z., & Gong, Z. (2023). Generation of albino phenotype in ornamental fish by CRISPR/Cas9-mediated genome editing of slc45a2 gene. Marine Biotechnology, 25(2), 281-290. doi:https://doi.org/10.1007/s10126-023-10204-9
13. Mayo Clinic. (n.d.). Albinism – Diagnosis and treatment. https://www.mayoclinic.org/diseases-conditions/albinism/diagnosis-treatment/drc-20369189
14. Gros, M. (n.d.). A woman with red lipstick holding a plant [Photograph]. Unsplash. https://unsplash.com/photos/a-woman-with-red-lipstick-holding-a-plant-yA822zo2fKY
15. Bales TR, Lopez MJ, Clark J. Embryology, Eye. [Updated 2023 Mar 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538480/
16. Ather, S., Proudlock, F. A., Welton, T., Morgan, P. S., Sheth, V., Gottlob, I., & Dineen, R. A. (2019). Aberrant visual pathway development in albinism: From retina to cortex. Human brain mapping, 40(3), 777–788. https://doi.org/10.1002/hbm.24411
17. McCafferty, B. K., Wilk, M. A., McAllister, J. T., Stepien, K. E., Dubis, A. M., Brilliant, M. H., Anderson, J. L., Carroll, J., & Summers, C. G. (2015). Clinical Insights Into Foveal Morphology in Albinism. Journal of pediatric ophthalmology and strabismus, 52(3), 167–172. https://doi.org/10.3928/01913913-20150427-06
18. Grubbs H, Nassereddin A, Morrison M. Embryology, Hair. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534794/
19. Millar, S. E. (2002). Molecular mechanisms regulating hair follicle development. Journal of Investigative Dermatology, 118(2), 216–225. https://doi.org/10.1046/j.0022-202x.2001.01670.x
20. Botchkareva, N. V., Botchkarev, V. A., & Gilchrest, B. A. (2003). Fate of melanocytes during development of the hair follicle pigmentary unit. Journal of Investigative Dermatology, 121(3), 550–557. https://doi.org/10.1046/j.1523-1747.2003.12176.x
21. Yamaguchi, Y., Brenner, M., & Hearing, V. J. (2007). The regulation of skin pigmentation. Journal of Biological Chemistry, 282(38), 27557–27561. https://doi.org/10.1074/jbc.R700026200
22. Yoshida, H., Grimm, T., Nishimura, E. K., Nishioka, E., Nishikawa, S.-I., & Kunisada, T. (2001). Review: Melanocyte migration and survival controlled by SCF/c-kit expression. Journal of Investigative Dermatology Symposium Proceedings, 6(1), 1–5. https://doi.org/10.1046/j.0022-202x.2001.00006.x
23. Bae-Harboe, Y.-S. C., & Park, H.-Y. (2012). Tyrosinase: A central regulatory protein for cutaneous pigmentation [Commentary]. Journal of Investigative Dermatology, 132(12), 2678–2680. https://doi.org/10.1038/jid.2012.324
24. Bin, B.-H., Bhin, J., Yang, S. H., Shin, M., Nam, Y.-J., Choi, D.-H., Shin, D. W., Lee, A.-Y., Hwang, D., Cho, E.-G., & Lee, T. R. (2015, June 9). Membrane‑Associated Transporter Protein (MATP) regulates melanosomal pH and influences tyrosinase activity. PLoS ONE, 10(6), e0129273. https://doi.org/10.1371/journal.pone.0129273
25. Park, S., Morya, V. K., Nguyen, D. H., Singh, B. K., Lee, H., & Kim, E. (2015). Unrevealing the role of P-protein on melanosome biology and structure, using siRNA-mediated down regulation of OCA2. Molecular and Cellular Biochemistry, 403(1-2), 61-71. https://doi.org/10.1007/s11010-015-2337-y
26. D’Mello, S. A. N., Finlay, G. J., Baguley, B. C., & Askarian-Amiri, M. E. (2016). Signaling pathways in melanogenesis. International Journal of Molecular Sciences, 17(7), 1144. https://doi.org/10.3390/ijms17071144
27. Sun, W., Shen, Y., Shan, S., Han, L., Li, Y., Zhou, Z., Zhong, Z., & Chen, J. (2018). Identification of TYR mutations in patients with oculocutaneous albinism. Molecular Medicine Reports, 17(6), 8409–8413. https://doi.org/10.3892/mmr.2018.8881
28. MedlinePlus Genetics. (n.d.). SLC45A2 gene [Genetics Home Reference]. Bethesda, MD: National Library of Medicine (U.S.); [updated March 1, 2007; cited June 9, 2025]. Retrieved from https://medlineplus.gov/genetics/gene/slc45a2/
29. National Cancer Institute, Office of Technology Transfer. (n.d.). Tyrosinase gene therapy for oculocutaneous albinism type 1A (TAB‑4991) [Technology description]. U.S. Department of Health and Human Services. Retrieved June 9, 2025, from https://techtransfer.cancer.gov/available‑technologies?abstract=TAB‑4991
30. Liu, S., Kuht, H. J., Moon, E. H., Maconachie, G. D. E., & Thomas, M. G. (2021). Current and emerging treatments for albinism. Survey of Ophthalmology, 66(2), 362–377. https://doi.org/10.1016/j.survophthal.2020.10.007
31. Luo, L., Ma, M., Yang, Y., & Zhao, H. (2025). Case Report: Genetic analysis of oculocutaneous albinism type 2 caused by a new mutation in the OCA2. Frontiers in pediatrics, 13, 1508198. https://doi.org/10.3389/fped.2025.1508198
32. National Eye Institute. (2022, January 11). NIH researchers develop first stem cell model of albinism to study related eye conditions. National Institutes of Health. https://www.nih.gov/news-events/news-releases/nih-researchers-develop-first-stem-cell-model-albinism-study-related-eye-conditions
33. Wu, K.-C., Zhang, C.-J., Liu, Q., Jin, Z.-B., & Zhang, M. (2020). Nonhuman primate model of oculocutaneous albinism with TYR and OCA2 mutations. Research (Washington, D.C.), 2020, 1658678. https://doi.org/10.34133/2020/1658678